Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis.
Louis E, Paridaens K, Al Awadhi S, Begun J, Cheon JH, Dignass AU, Magro F, Márquez JR, Moschen AR, Narula N, Rydzewska G, Freddi MJ, Travis SP.
Louis E, et al. Among authors: moschen ar.
BMJ Open Gastroenterol. 2022 Feb;9(1):e000853. doi: 10.1136/bmjgast-2021-000853.
BMJ Open Gastroenterol. 2022.
PMID: 35165124
Free PMC article.